Variant report
Variant | nsv822595 |
---|---|
Chromosome Location | chr4:69970742-69971602 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr4:69964055..69967936-chr4:69969110..69971498,3 | K562 | blood: |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs148631099 | chr4:69970758-69970759 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs535503197 | chr4:69970839-69970840 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs555504456 | chr4:69970861-69970862 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs575458157 | chr4:69970875-69970876 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs10028494 | chr4:69970937-69970938 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
6 | rs3924192 | chr4:69970964-69970965 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
7 | rs143248219 | chr4:69970968-69970969 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs200457644 | chr4:69970974-69970975 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs369802309 | chr4:69970976-69970977 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs3924193 | chr4:69970991-69970992 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs559659801 | chr4:69971008-69971009 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs573113089 | chr4:69971035-69971036 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs562481560 | chr4:69971074-69971075 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs3924194 | chr4:69971092-69971093 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
15 | rs530945569 | chr4:69971144-69971145 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs114274672 | chr4:69971169-69971170 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs146676198 | chr4:69971183-69971184 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs531657857 | chr4:69971245-69971246 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs75875847 | chr4:69971267-69971268 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs78739827 | chr4:69971271-69971272 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs566621825 | chr4:69971275-69971276 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs7435335 | chr4:69971335-69971336 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
23 | rs193259754 | chr4:69971338-69971339 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs140230215 | chr4:69971476-69971477 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs144174554 | chr4:69971486-69971487 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs557443506 | chr4:69971492-69971493 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs577584171 | chr4:69971500-69971501 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs150997702 | chr4:69971510-69971511 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs553635171 | chr4:69971560-69971561 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs573239262 | chr4:69971574-69971575 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs10050146 | chr4:69971576-69971577 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
32 | rs561971586 | chr4:69971591-69971592 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs6600891 | chr4:69971596-69971597 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
Disease | PMID | Source |
---|---|---|
Gastrointestinal stromal cancer | 16982739 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Chordoma | 21602918 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Breast cancer | 21858162 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Gastric cancer | 21586687 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Melanoma | 18172304 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 17603634 | CNVD |
Glioblastoma multiforme | 21922591 | CNVD |
Parkinson disease | 21956041 | CNVD |
Mental retardation | 20522426 | CNVD |
delayed speech | 20522426 | CNVD |
growth disorder | 20522426 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Parkinson disease | 18923514 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 16272173 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
4q-syndrome | 17576883 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Muscular dystrophy | 21149563 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cervical cancer | 21062161 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Breast cancer | 16608533 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
Lung cancer | 19208797 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 21785460 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Prostate cancer | 16573809 | CNVD |
Osteoporosis | 18992858 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Graft versus host disease | 20877625 | CNVD |
Breast cancer | 21990379 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Osteoporosis | 20877625 | CNVD |
Osteoporosis | 19737800 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18316590 | CNVD |
Glioblastoma multiforme | 21138945 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Breast cancer | 22522925 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr4:69959600-69980000 | Weak transcription | H1 Derived Mesenchymal Stem Cells | ES cell derived |
2 | chr4:69963000-69982000 | Weak transcription | Duodenum Mucosa | Duodenum |
3 | chr4:69967200-69971400 | Enhancers | HepG2 | liver |
4 | chr4:69967400-69971000 | Enhancers | Liver | Liver |
5 | chr4:69970000-69980400 | Weak transcription | Fetal Intestine Small | intestine |
6 | chr4:69970400-69970800 | Enhancers | Rectal Mucosa Donor 29 | rectum |
7 | chr4:69970400-69971200 | Enhancers | Fetal Intestine Large | intestine |
8 | chr4:69970400-69971400 | Enhancers | Rectal Mucosa Donor 31 | rectum |
9 | chr4:69970600-69971000 | Enhancers | Gastric | stomach |
10 | chr4:69970600-69971000 | Enhancers | Pancreas | Pancrea |
11 | chr4:69970600-69971000 | Enhancers | NHEK | skin |
12 | chr4:69971000-69972000 | Weak transcription | Liver | Liver |
13 | chr4:69971000-69981200 | Weak transcription | Pancreas | Pancrea |
14 | chr4:69971400-69981400 | Weak transcription | HepG2 | liver |